Company Profile

Sonavex Inc (AKA: Veridian Surgical, LLC)
Profile last edited on: 9/27/2022      CAGE: 70ZR7      UEI: EFQ8AGCC5HK7

Business Identifier: Imaging technology: visualize and quantify critical data to detect anastomotic blood clots
Year Founded
2013
First Award
2015
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2835 O'Donnell Street Suite 200
Baltimore, MD 21224
   (443) 862-2024
   info@sonavex.com
   www.sonavex.com
Location: Single
Congr. District: 07
County: Baltimore City

Public Profile

Previously dba Veridian Surgical, LLC, Sonavex is a Johns Hopkins spin out developing medical imaging technology for detection of anastomotic blood clots - designed to provide clinicians with visualization of critical data directly at the point of care. Designated EchoSure, one of the firm's products detects blood clots prior to catastrophic and expensive surgical failures. The company's product EchoMark is a soft tissue marker used to mark surgical sites with ultrasound. Each year, hundreds of thousands of patients in the US undergo open surgical procedures that could benefit from post-operative ultrasound imaging to assess the surgical region or locate the original surgical site for additional procedures. One commonly known example is breast lumpectomy, where positive margins are found in more than 20% of cases, requiring re-excision. The ability to identify the surgical site in these cases is also beneficial for evaluating potential recurrences and guiding needle biopsies.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  David Narrow -- Founder and CEO

  Devin O'Brien Coon -- President & Chief Medical Officer

  Gerry Buss -- Director of Regulatory Affairs and Quality Assurance

  Devin Coon -- Founder

  Katy Feeny -- Director of Clinical Affairs

  Harish P Hiriyannaiah -- Chief Technical Officer

  Xin (Ben) Kang -- Director of Research & Development

  John Rappe -- Chief Business Officer

  Alex Yevzlin -- Chief Medical Officer

  Michelle Zwernemann -- VP of Regulatory Affairs & Quality Assurance

Company News

There are no news available.